[The results of the repeat treatment of primary resistant hematosarcomas].
The paper discusses the immediate and end results of second-line treatment of 186 cases of hematosarcoma who failed primary therapy. The results were evaluated versus gender, age, histology, stage, site of disease, primary treatment as well as pattern and degree of primary resistance.
Kruglova
G V
GV
Aliev
D A
DA
Samedov
I V
IV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality; D016400:Lymphoma, Large-Cell, Immunoblastic / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction